Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lymphoma, Primary Cutaneous Anaplastic Large Cell
Welcome,
Profile
Billing
Logout
0 Companies
0 Products
0 Products
5 Mechanisms of Action
0 Trials
1 News
|
|||||||||
Trial completion:
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
(clinicaltrials.gov) - Dec 17, 2014
P2
, N=40, Completed,
Sponsor: Seattle Genetics, Inc.
No longer recruiting --> Completed